Risk factors for oligodendroglial tumors: a pooled international studyEndogenous antibody responsiveness to epidermal growth factor receptor is associated with immunoglobulin allotypes and overall survival of patients with glioblastomaOccupational exposure to magnetic fields and the risk of brain tumorsAbstracts for the Thirteenth Annual Meeting of the Society for Neuro-OncologyAbstracts from the World Federation of Neuro-Oncology Second Quadrennial Meeting and the Sixth Meeting of the European Association for Neuro-OncologyProtein kinase C-eta regulates resistance to UV- and gamma-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activationNeuralized1 causes apoptosis and downregulates Notch target genes in medulloblastomaTreatment of medulloblastoma with a modified measles virusAdult ependymal tumors: prognosis and the M. D. Anderson Cancer Center experienceChloroquine activates the p53 pathway and induces apoptosis in human glioma cellsO6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patientsBevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expressionConsensus on the role of human cytomegalovirus in glioblastomaMultifactorial analysis of predictors of outcome in pediatric intracranial ependymomaDifferential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysisPTPmu suppresses glioma cell migration and dispersalIn Tribute to Mike Traynor (1939-2009)Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspectiveMolecular cloning and identification of the human interleukin 13 alpha 2 receptor (IL-13Ra2) promoterA phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952Quality of health information on the Internet in pediatric neuro-oncologyThe role of pericytes in blood-vessel formation and maintenanceScatter factor/hepatocyte growth factor in brain tumor growth and angiogenesisMicroarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3A collaborative study of the epidemiology of oligodendroglial tumorsConsensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trialsSevere sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting systemAutoimmune encephalitis updateThe biology of radiosurgery and its clinical applications for brain tumors.Circulating glioma biomarkersSui generis: gene therapy and delivery systems for the treatment of glioblastomaChallenges to targeting epidermal growth factor receptor in glioblastoma: escape mechanisms and combinatorial treatment strategiesCurrent standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patientsRole of Eph/ephrin tyrosine kinase in malignant gliomaIonizing radiation and the risk of brain and central nervous system tumors: a systematic reviewTargeted molecular therapies against epidermal growth factor receptor: past experiences and challengesIn vivo models of primary brain tumors: pitfalls and perspectives.Immunotherapy advances for glioblastomaMedical management of brain tumors and the sequelae of treatment.
P1433
Q23910577-A66B8C25-10BF-45B4-8A32-18B3770DC041Q23914429-E48006FA-7DE8-4D0B-B7CA-144CA64CF2B6Q23915403-BFFA3A94-090F-46F1-B441-5284040B591AQ23924511-2391FC70-2B80-4907-85C0-7EDBC4BFF157Q23924512-B322EFA6-67C2-48B7-8FED-93476B033C1FQ24292077-AE800543-0BD1-4CB8-AF3F-DC5D2ACE3936Q24300058-524EA9EA-4488-46E0-BE9C-FF40B7078BE6Q24602003-24D38C3E-908B-4513-9322-8AF1E1719940Q24607694-A6A6D964-A2F9-4577-8555-C833E56DBA2FQ24607826-27B1221E-DFD3-4329-A68B-4B3EC4DD3636Q24607903-57E7F102-A08D-49B6-B710-6AE993526CE9Q24607986-C7CC1ACD-E741-4627-B9E4-740955570B59Q24610377-7DF80FEB-D7CD-455B-9F38-6CF203094A97Q24632103-5E1E058C-DD10-4853-9C06-AB607C2E4694Q24646111-15599FC3-0C9E-424C-89D9-B108FE4C3A3CQ24646189-7DBD7568-492B-4010-BBE3-05828C64812FQ24650475-9FECBCA5-A5B7-4FF9-8FB4-77283C5414DAQ24650520-5EB2E419-F332-45B1-80A0-218B8D609CC7Q24658389-35B92A85-158A-45EE-9604-7D8A6CFE1D04Q24671715-34CEDB38-94E8-4962-BE22-939A551A4214Q24671734-491217B4-7A9B-4E90-859B-9CD2193B6B57Q24683739-C6B55ED0-1F8C-4E7A-A4EC-8DC3DCF236E7Q24683881-756D69ED-7FA0-4EF7-A2FC-CA19389A2066Q24683896-AC10BB26-BB07-4B8D-AA71-4E9D01A07373Q24683906-80EE20D4-0A36-4210-A1D6-BA7366DE8259Q24717616-C5530469-7B82-4288-B0CF-55BCCC9A1AD5Q26801351-E2BA78CD-5ED2-4BCE-AB8B-5AE909F0BB35Q26824754-E71BF207-530B-4194-8CAE-BB6A161E318DQ26827114-256D258B-F6CE-4ACF-8904-A85BE71C354EQ26829154-C73DA22A-B84F-4E3A-9071-8A53A97CF6C0Q26830329-3152FDC8-D271-4D7E-BE19-175252C9EAD0Q26850467-B734F049-6C5C-4CCD-8984-8814C7250016Q26852366-F029FFA4-B738-4BF8-A56E-EDB711EA45D5Q26853308-51A2706A-A5A7-4AEE-B596-EA667B4263AAQ26860972-A2673CDC-6FA0-4D0F-A69E-5823BC66533BQ26862426-BA827B45-05E8-41F8-8644-4D413CE52E32Q26862516-E2297027-355C-4182-A57E-65D3C06F1F78Q26862847-808A45AD-01F9-4672-B984-E22132177972Q26866513-3E7BDC82-8C0B-4008-B995-123A0CD0C6E3Q26992174-10AD8901-ED1F-4F4C-B0D3-1011E42A626A
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Oxford University Press
@nl
рецензований науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
name
Neuro-Oncology
@ast
Neuro-Oncology
@de
Neuro-Oncology
@en
Neuro-Oncology
@es
Neuro-Oncology
@fr
Neuro-Oncology
@it
Neuro-Oncology
@nl
type
label
Neuro-Oncology
@ast
Neuro-Oncology
@de
Neuro-Oncology
@en
Neuro-Oncology
@es
Neuro-Oncology
@fr
Neuro-Oncology
@it
Neuro-Oncology
@nl
prefLabel
Neuro-Oncology
@ast
Neuro-Oncology
@de
Neuro-Oncology
@en
Neuro-Oncology
@es
Neuro-Oncology
@fr
Neuro-Oncology
@it
Neuro-Oncology
@nl
P243
P3181
P1055
P1058
P1156
P1159
P1277
P1476
Neuro-Oncology
@en
P236
P243
P3181
P3417
Neuro-Oncology
P407
P571
1999-01-01T00:00:00Z